HNB
ZOM

Huntington National Bank’s Zomedica Corp. ZOM Stock Holding History

Huntington National Bank’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,000
Closed -$1K – 2518
2021
Q4 		$1K Buy
+4,000
New +$1.8K ﹤0.01% 1987

Other funds holding ZOM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BBHC
Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Huntington National Bank's ZOM Position: Q1 2022 in Review

Huntington National Bank sold out of Zomedica Corp. (ZOM) in Q1 2022, closing a stake of 4,000 shares — an estimated $1K sold.

Huntington National Bank first reported a position in ZOM in Q4 2021 and held it in 1 quarter. The position peaked at $1K in Q4 2021. 110 funds tracked by Wall St. Rank hold ZOM as of Q1 2022.

  • Huntington National Bank reported no remaining Zomedica Corp. position as of Q1 2022 after selling out during the quarter.
  • Huntington National Bank sold 4,000 Zomedica Corp. shares in Q1 2022, an estimated $1K.
  • Huntington National Bank first reported a position in Zomedica Corp. in Q4 2021 and held it in 1 quarter.
  • Huntington National Bank's Zomedica Corp. position peaked at $1K in Q4 2021.
  • 110 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2022.

Based on Huntington National Bank's 13F filing for Q1 2022, filed 10 May 2022.